|
1
|
Su SC, Lin CW, Liu YF, Fan WL, Chen MK, Yu
CP, Yang WE, Su CW, Chuang CY, Li WH, et al: Exome sequencing of
oral squamous cell carcinoma reveals molecular subgroups and novel
therapeutic opportunities. Theranostics. 7:1088–1099. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan L, Chen F, Liu F, Qiu Y, Wang J, Wu J,
Bao X, Hu Z, Peng X, Lin X, et al: Differences in modifiable
factors of oral squamous cell carcinoma in the upper and lower of
oral fissure. Oncotarget. 8:75094–75101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glazer CA, Chang SS, Ha PK and Califano
JA: Applying the molecular biology and epigenetics of head and neck
cancer in everyday clinical practice. Oral Oncol. 45:440–446. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LL and Yang L: Regulation of circRNA
biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsiao KY, Sun HS and Tsai SJ: Circular
RNA-New member of noncoding RNA with novel functions. Exp Biol Med
(Maywood). 242:1136–1141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lasda E and Parker R: Circular RNAs:
Diversity of form and function. RNA. 20:1829–1842. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holdt LM, Kohlmaier A and Teupser D:
Molecular roles and function of circular RNAs in eukaryotic cells.
Cell Mol Life Sci. 75:1071–1098. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao D, Zhang X, Liu B, Meng D, Fang K, Guo
Z and Li L: Screening circular RNA related to chemotherapeutic
resistance in breast cancer. Epigenomics. 9:1175–1188. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kristensen LS, Hansen TB, Veno MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meyer KB, Maia AT, O'Reilly M, Ghoussaini
M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L,
Carroll J and Ponder BA: A functional variant at a prostate cancer
predisposition locus at 8q24 is associated with PVT1 expression.
PLoS Genet. 7:e10021652011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu D, Luo P, Wang Q, Ye Y and Wang B:
lncRNA PVT1 in cancer: A review and meta-analysis. Clin Chim Acta.
474:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Li Y, Zheng Q, Bao C, He J, Chen
B, Lyu D, Zheng B, Xu Y, Long Z, et al: Circular RNA profile
identifies circPVT1 as a proliferative factor and prognostic marker
in gastric cancer. Cancer Lett. 388:208–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verduci L, Ferraiuolo M, Sacconi A, Ganci
F, Vitale J, Colombo T, Paci P, Strano S, Macino G, Rajewsky N and
Blandino G: The oncogenic role of circPVT1 in head and neck
squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD
transcription-competent complex. Genome Biol. 18:2372017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao M, Sano D, Pickering CR, Jasser SA,
Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, et
al: Assembly and initial characterization of a panel of 85
genomically validated cell lines from diverse head and neck tumor
sites. Clin Cancer Res. 17:7248–7264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dai CY, Tsai YS, Chou WW, Liu T, Huang CF,
Wang SC, Tsai PC, Yeh ML, Hsieh MY, Huang CI, et al: The IL-6/STAT3
pathway upregulates microRNA-125b expression in hepatitis C virus
infection. Oncotarget. 9:11291–11302. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gorczynski RM, Alexander C, Brandenburg K,
Chen Z, Heini A, Neumann D, Mach JP, Rietschel ET, Terskikh A,
Ulmer AJ, et al: Corrigendum to ‘An altered REDOX environment,
assisted by over-expression of fetal hemoglobins, protects from
inflammatory colitis and reduces inflammatory cytokine expression’
[Int. Immunopharmacol. 50 (2017) 69–76]. Int Immunopharmacol.
59:4142018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
MacPherson S, Horkoff M, Gravel C,
Hoffmann T, Zuber J and Lum JJ: STAT3 regulation of citrate
synthase is essential during the initiation of lymphocyte cell
growth. Cell Rep. 19:910–918. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Momen-Heravi F and Bala S: Emerging role
of non-coding RNA in oral cancer. Cell Signal. 42:134–143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Zhang X, Wang H, Wang L, Liu T, Du
L, Yang Y and Wang C: MALAT1 is associated with poor response to
oxaliplatin-based chemotherapy in colorectal cancer patients and
promotes chemoresistance through EZH2. Mol Cancer Ther. 16:739–751.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J, Meng X, Pan J, Jiang N, Zhou C, Wu
Z and Gong Z: CRISPR/Cas9-mediated noncoding RNA editing in human
cancers. RNA Biology. 15:35–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamam R, Hamam D, Alsaleh KA, Kassem M,
Zaher W, Alfayez M, Aldahmash A and Alajez NM: Circulating
microRNAs in breast cancer: Novel diagnostic and prognostic
biomarkers. Cell Death Dis. 8:e30452017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen
L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66
promote colon cancer growth and metastasis. Cancer Res.
77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanwal R, Plaga AR, Liu X, Shukla GC and
Gupta S: MicroRNAs in prostate cancer: Functional role as
biomarkers. Cancer Lett. 407:9–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ungerleider N, Jain V, Wang Y, Maness NJ,
Blair RV, Alvarez X, Midkiff C, Kolson D, Bai S, Roberts C, et al:
Comparative analysis of gammaherpesvirus circRNA repertoires:
Conserved and unique viral circular RNAs. J Virol. 93(pii):
e01952–18. 2019.PubMed/NCBI
|
|
28
|
Du WW, Zhang C, Yang W, Yong T, Awan FM
and Yang BB: Identifying and characterizing circRNA-protein
interaction. Theranostics. 7:4183–4191. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greene J, Baird AM, Brady L, Lim M, Gray
SG, McDermott R and Finn SP: Circular RNAs: Biogenesis, Function
and Role in Human Diseases. Front Mol Biosci. 4:382017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rong D, Sun H, Li Z, Liu S, Dong C, Fu K,
Tang W and Cao H: An emerging function of circRNA-miRNAs-mRNA axis
in human diseases. Oncotarget. 8:73271–73281. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu J, Han Q, Gu Y, Ma J, McGrath M, Qiao
F, Chen B, Song C and Ge Z: Circular RNA PVT1 expression and its
roles in acute lymphoblastic leukemia. Epigenomics. 10:723–732.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mali SB: Review of STAT3 (Signal
Transducers and Activators of Transcription) in head and neck
cancer. Oral Oncol. 51:565–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Sepich DS and Solnica-Krezel L:
Stat3/Cdc25a-dependent cell proliferation promotes embryonic axis
extension during zebrafish gastrulation. PLoS Genet.
13:e10065642017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Cui J, Zhang J, Liu Y, Han L, Jia C,
Deng J and Liang H: PIAS3, an inhibitor of STAT3, has intensively
negative association with the survival of gastric cancer. Int J
Clin Exp Med. 8:682–689. 2015.PubMed/NCBI
|
|
37
|
Kanda N, Seno H, Konda Y, Marusawa H,
Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y,
et al: STAT3 is constitutively activated and supports cell survival
in association with survivin expression in gastric cancer cells.
Oncogene. 23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
